AC8 0.00% 4.0¢ auscann group holdings ltd

phase 1b studies can be done within a couple months and as soon...

  1. 2,071 Posts.
    lightbulb Created with Sketch. 564
    phase 1b studies can be done within a couple months and as soon as their was clinical evidence they are going to market the product. they also stated they were not interested in going the full FDA path. so I'm not too sure why the 5/8 year comment was made...

    not 100% clear. also no mention of exploring complementary products as yet?
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.